Curaleaf Holdings (CURLF) Non Operating Investment Income (2023 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Non Operating Investment Income of $1.2 million in Q2 2025, up 288.32% quarter-over-quarter from -$642000.0 in Q3 2024, and up 168.15% on a YoY basis from $450865.3 in Q2 2024.
Curaleaf Holdings (CURLF) Non Operating Investment Income (2023 - 2025) Analysis & Trends
Curaleaf Holdings' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $1.2 million for Q2 2025.
- In Q2 2025, Non Operating Investment Income rose 168.15% year-over-year to $1.2 million; the TTM figure through Jun 2025 stood at $2.7 million (changed N/A YoY), while the FY2021 annual figure was $2.1 million, down 94.43% from the prior year.
- Non Operating Investment Income was $1.2 million for Q2 2025 at Curaleaf Holdings, up from -$642000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $3.9 million in Q1 2024 to a low of -$24.8 million in Q3 2023.
- Historically, Non Operating Investment Income has averaged -$4.4 million across 3 years, with a median of -$642000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Non Operating Investment Income surged 97.41% in 2024, then soared 168.15% in 2025.
- A 3-year view of Non Operating Investment Income shows it stood at -$24.8 million in 2023, then soared by 97.41% to -$642000.0 in 2024, then surged by 288.32% to $1.2 million in 2025.
- The last three Non Operating Investment Income figures came in at $1.2 million (Q2 2025), -$642000.0 (Q3 2024), and -$1.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Sep 30, 2024 | -642,000.00 |
| Sep 30, 2024 | -642,000.00 |
| Jun 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | -1.77 Mn |
| Mar 31, 2024 | 3.93 Mn |
| Mar 31, 2024 | 3.93 Mn |
| Sep 30, 2023 | -24.79 Mn |
| Sep 30, 2023 | -24.79 Mn |